JP2012511914A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2012511914A5 JP2012511914A5 JP2011540984A JP2011540984A JP2012511914A5 JP 2012511914 A5 JP2012511914 A5 JP 2012511914A5 JP 2011540984 A JP2011540984 A JP 2011540984A JP 2011540984 A JP2011540984 A JP 2011540984A JP 2012511914 A5 JP2012511914 A5 JP 2012511914A5
- Authority
- JP
- Japan
- Prior art keywords
- virus
- strain
- derived
- genes
- influenza
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US12296108P | 2008-12-16 | 2008-12-16 | |
| US61/122,961 | 2008-12-16 | ||
| PCT/US2009/068321 WO2010077986A2 (en) | 2008-12-16 | 2009-12-16 | Production of viral vaccine |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2012511914A JP2012511914A (ja) | 2012-05-31 |
| JP2012511914A5 true JP2012511914A5 (enExample) | 2013-02-07 |
| JP5686741B2 JP5686741B2 (ja) | 2015-03-18 |
Family
ID=41666658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011540984A Active JP5686741B2 (ja) | 2008-12-16 | 2009-12-16 | インフルエンザワクチンの生成 |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US9884105B2 (enExample) |
| EP (1) | EP2376628B1 (enExample) |
| JP (1) | JP5686741B2 (enExample) |
| KR (1) | KR20110113615A (enExample) |
| CN (2) | CN107365751B (enExample) |
| AU (2) | AU2009333208A1 (enExample) |
| BR (1) | BRPI0923448A2 (enExample) |
| ES (1) | ES2675771T3 (enExample) |
| SG (1) | SG172220A1 (enExample) |
| WO (1) | WO2010077986A2 (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011136738A1 (en) * | 2010-04-30 | 2011-11-03 | Temasek Life Sciences Laboratory Limited | Universal vaccine against h5n1 lineages |
| KR101250005B1 (ko) | 2010-12-31 | 2013-04-03 | 연세대학교 산학협력단 | 바이러스 유전자 조작을 통한 생백신 제조방법 |
| ES2628301T3 (es) * | 2012-03-02 | 2017-08-02 | Seqirus UK Limited | Recombinación de virus de gripe |
| AU2013354219A1 (en) | 2012-12-03 | 2015-07-02 | Novartis Ag | Reassortant influenza a viren |
| HK1218511A1 (zh) | 2013-03-13 | 2017-02-24 | Novartis Ag | 乙型流感病毒重配 |
| CN104073513B (zh) * | 2013-03-25 | 2018-04-20 | 中国科学院上海巴斯德研究所 | 甲型流感病毒疫苗哺乳动物细胞适应株的获得方法和适应位点 |
| JP2016521282A (ja) * | 2013-05-10 | 2016-07-21 | ノバルティス アーゲー | インフルエンザワクチンにおけるナルコレプシーのリスクの回避 |
| CN105483149A (zh) * | 2015-12-25 | 2016-04-13 | 吉林农业大学 | 广谱型抗禽流感重组乳酸菌及其制备方法 |
| CN105950789A (zh) * | 2016-07-14 | 2016-09-21 | 广西壮族自治区兽医研究所 | 一种鉴定h5亚型aiv、n6亚型aiv和aiv的引物组合及其应用 |
| KR101966346B1 (ko) * | 2017-01-13 | 2019-04-05 | 전북대학교 산학협력단 | 시가 독소 Stx2e를 제조하는 방법 및 이를 포함하는 부종병을 예방하기 위한 백신 조성물 |
| WO2019044636A1 (ja) | 2017-08-28 | 2019-03-07 | 一般財団法人阪大微生物病研究会 | リアソータントインフルエンザウイルスの段階的作出方法 |
| KR102182987B1 (ko) * | 2018-06-27 | 2020-11-27 | 대한민국 | 재조합 인플루엔자 a 바이러스 h5n1주 및 이를 포함하는 고병원성 인플루엔자 a 바이러스 백신 조성물 |
| CN109096377B (zh) * | 2018-09-19 | 2021-03-23 | 天康生物股份有限公司 | 禽流感病毒血凝素抗原及表达其的bhk-21细胞株、制备方法和疫苗 |
| CN109134624A (zh) * | 2018-09-19 | 2019-01-04 | 天康生物股份有限公司 | 禽流感病毒血凝素抗原及其制备方法、应用和禽流感疫苗 |
| KR102182999B1 (ko) * | 2019-01-04 | 2020-11-25 | 대한민국 | 재조합 인플루엔자 A 바이러스 및 이를 포함하는 clade 2.3.4.4B에 속하는 H5 혈청형 인플루엔자 A 바이러스에 대한 백신 조성물 |
| KR102182997B1 (ko) * | 2019-01-04 | 2020-11-26 | 대한민국 | H5N6형 재조합 인플루엔자 A 바이러스 및 이를 포함하는 clade 2.3.4.4D에 속하는 H5 혈청형 인플루엔자 A 바이러스에 대한 백신 조성물 |
| CN111647610B (zh) * | 2020-06-02 | 2021-09-03 | 扬州大学 | 一种互换ha和ns1缺失基因包装信号的h9n2亚型禽流感病毒及其构建方法和应用 |
| WO2021257469A1 (en) * | 2020-06-15 | 2021-12-23 | Icahn School Of Medicine At Mount Sinai | Immunoassay for the detection of anti-sars-cov-2 spike protein antibody in milk samples |
| CN114524862B (zh) * | 2021-12-16 | 2022-12-27 | 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） | 禽流感(h5+h7)三价dna疫苗的构建及其应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4552758A (en) | 1983-12-20 | 1985-11-12 | St. Jude Children's Research Hospital | Human use of avian-human reassortants as vaccines for influenza A virus |
| JPH0832638B2 (ja) | 1989-05-25 | 1996-03-29 | カイロン コーポレイション | サブミクロン油滴乳剤を含んで成るアジュバント製剤 |
| US6001634A (en) | 1989-08-28 | 1999-12-14 | Palese; Peter | Recombinant negative strand RNA viruses |
| US6022726A (en) | 1992-02-03 | 2000-02-08 | Palese; Peter | Genetically engineered attenuated viruses |
| US7344722B1 (en) | 1993-06-29 | 2008-03-18 | The Regents Of The University Of Michigan | Cold-adapted influenza virus |
| GB9326253D0 (en) | 1993-12-23 | 1994-02-23 | Smithkline Beecham Biolog | Vaccines |
| US6146873A (en) | 1994-11-10 | 2000-11-14 | Baxter Aktiengesellschaft | Production of orthomyxoviruses in monkey kidney cells using protein-free media |
| US6254873B1 (en) | 1995-04-17 | 2001-07-03 | The United States Of America As Represented By The Secretary Of The Army | Inactivated dengue virus vaccine |
| US5840565A (en) | 1995-08-22 | 1998-11-24 | The Regents Of The University Of California | Methods for enhancing the production of viral vaccines in PKR-deficient cell culture |
| DK2316923T3 (en) | 1998-06-12 | 2018-01-08 | Icahn School Med Mount Sinai | Attenuated influenza viruses with altered interferon antagonist activity for use as vaccines and drugs |
| EP1098961B1 (en) | 1998-06-12 | 2008-01-16 | Mount Sinai School Of Medicine Of The City University Of New York | Interferon inducing genetically engineered attenuated viruses |
| AT407958B (de) | 1999-02-11 | 2001-07-25 | Immuno Ag | Inaktivierte influenza-virus-vakzine zur nasalen oder oralen applikation |
| US7521220B2 (en) * | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
| US6803041B2 (en) | 2001-03-20 | 2004-10-12 | Boehringer Ingelheim Vetmedica, Inc. | Equine herpesvirus vaccine |
| CN1678345A (zh) | 2002-04-26 | 2005-10-05 | 米迪缪尼疫苗股份有限公司 | 制备流感病毒的多质粒系统 |
| US7465456B2 (en) | 2002-04-26 | 2008-12-16 | Medimmune, Llc | Multi plasmid system for the production of influenza virus |
| CA2807534A1 (en) | 2003-02-25 | 2005-02-17 | Medimmune Vaccines, Inc. | Methods of producing influenza vaccine compositions |
| US20060110406A1 (en) | 2003-02-25 | 2006-05-25 | Medimmune Vaccines, Inc. | Refrigerator-temperature stable influenza vaccine compositions |
| US7566458B2 (en) | 2003-06-16 | 2009-07-28 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| US7037707B2 (en) | 2003-09-04 | 2006-05-02 | St. Jude Children's Research Hospital | Method for generating influenza viruses and vaccines |
| CN1618956A (zh) * | 2003-11-20 | 2005-05-25 | 中国科学院武汉病毒研究所 | 一种禽流感预防用病毒株及其动物感染模型 |
| ATE469972T1 (de) | 2003-12-23 | 2010-06-15 | Medimmune Llc | Multiplasmid-system zur erzeugung des grippevirus |
| WO2005115448A2 (en) | 2004-05-24 | 2005-12-08 | Medimmune Vaccines, Inc. | Multi plasmid system for the production of influenza virus |
| EP1766059B1 (en) | 2004-05-25 | 2012-07-11 | MedImmune Vaccines, Inc. | Influenza hemagglutinin and neuraminidase variants |
| US8124101B2 (en) | 2004-06-01 | 2012-02-28 | Mount Sinai School Of Medicine | Genetically engineered swine influenza virus and uses thereof |
| KR101376889B1 (ko) | 2004-10-06 | 2014-03-25 | 메디뮨 엘엘씨 | 냉장 온도 안정성 인플루엔자 백신 조성물 |
| CA2593036A1 (en) | 2004-12-08 | 2006-06-15 | Medimmune Vaccines, Inc. | Methods of producing influenza vaccine compositions |
| ES2527503T3 (es) | 2005-03-08 | 2015-01-26 | Medimmune, Llc | Virus influenza reordenantes |
| CA2891994A1 (en) | 2005-10-17 | 2007-04-26 | Bin Lu | Multi plasmid system for the production of influenza virus |
| US20080014217A1 (en) | 2006-07-17 | 2008-01-17 | Emmanuel Jules Hanon | Influenza vaccine |
| US7601356B2 (en) | 2006-07-21 | 2009-10-13 | Medimmune, Llc | Methods and compositions for increasing replication capacity of an influenza virus |
| AU2007286161B2 (en) | 2006-08-09 | 2013-05-02 | Medimmune, Llc | Influenza hemagglutinin and neuraminidase variants |
| EP2066358A1 (en) | 2006-09-26 | 2009-06-10 | ID Biomedical Corporation of Quebec | Device and methods of inactivating influenza virus and adventitious agents with ultraviolet light |
| EP2091561A2 (en) | 2006-12-15 | 2009-08-26 | Schering-Plough Ltd. | Method for replicating influenza virus in culture |
| EP2069484B1 (en) | 2007-06-18 | 2014-08-13 | MedImmune, LLC | Influenza B viruses having alterations in the hemaglutinin polypeptide |
-
2009
- 2009-12-16 ES ES09774806.5T patent/ES2675771T3/es active Active
- 2009-12-16 WO PCT/US2009/068321 patent/WO2010077986A2/en not_active Ceased
- 2009-12-16 AU AU2009333208A patent/AU2009333208A1/en not_active Abandoned
- 2009-12-16 BR BRPI0923448A patent/BRPI0923448A2/pt not_active IP Right Cessation
- 2009-12-16 KR KR1020117016500A patent/KR20110113615A/ko not_active Ceased
- 2009-12-16 JP JP2011540984A patent/JP5686741B2/ja active Active
- 2009-12-16 CN CN201710352474.6A patent/CN107365751B/zh active Active
- 2009-12-16 CN CN200980150850.7A patent/CN102257135B/zh active Active
- 2009-12-16 US US12/639,917 patent/US9884105B2/en active Active
- 2009-12-16 SG SG2011044385A patent/SG172220A1/en unknown
- 2009-12-16 EP EP09774806.5A patent/EP2376628B1/en active Active
-
2016
- 2016-02-19 AU AU2016201038A patent/AU2016201038A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012511914A5 (enExample) | ||
| Thomas et al. | Cell-mediated protection in influenza infection | |
| Hegde | Cell culture-based influenza vaccines: A necessary and indispensable investment for the future | |
| EP2493912B1 (en) | High titer recombinant influenza viruses with enhanced replication in vero cells | |
| Quan et al. | Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus | |
| CA2423038C (en) | Live vaccine and method of manufacture | |
| Quiñones-Parra et al. | Universal immunity to influenza must outwit immune evasion | |
| JP7627911B2 (ja) | 卵内複製のための安定化されたｈａを持つ組換えインフルエンザウイルス | |
| JP5686741B2 (ja) | インフルエンザワクチンの生成 | |
| JP6185548B2 (ja) | インフルエンザワクチンの製造方法 | |
| US20200188506A1 (en) | Vectors for eliciting immune responses to non-dominant epitopes in the hemagglutinin (ha) protein | |
| Osterhaus et al. | Towards universal influenza vaccines? | |
| Noh et al. | Influenza vaccines: unmet needs and recent developments | |
| Chua et al. | Inactivated influenza vaccine that provides rapid, innate-immune-system-mediated protection and subsequent long-term adaptive immunity | |
| Zhirnov et al. | Structural and evolutionary characteristics of HA, NA, NS and M genes of clinical influenza A/H3N2 viruses passaged in human and canine cells | |
| JP2016501020A5 (enExample) | ||
| Shin et al. | Comparison of immunogenicity of cell-and egg-passaged viruses for manufacturing MDCK cell culture-based influenza vaccines | |
| AU2016308917A1 (en) | Live-attenuated vaccine having mutations in viral polymerase for the treatment and prevention of canine influenza virus | |
| Haque et al. | Confronting potential influenza A (H5N1) pandemic with better vaccines | |
| Lee et al. | Genetic evolution of H5 highly pathogenic avian influenza virus in domestic poultry in Vietnam between 2011 and 2013 | |
| Zhou et al. | High-yield production of a stable Vero cell-based vaccine candidate against the highly pathogenic avian influenza virus H5N1 | |
| Rockman et al. | Pre-pandemic and pandemic influenza vaccines | |
| Horimoto et al. | Designing vaccines for pandemic influenza | |
| JP5889890B2 (ja) | 改変されたウイルス株およびインフルエンザウイルスのワクチンシードの生産を改善する方法 | |
| Šantak | Old and new ways to combat human influenza virus |